Thermo Fisher Scientific Inc. (LON:0R0H)
412.52
-9.74 (-2.31%)
At close: Jul 18, 2025
Thermo Fisher Scientific Revenue
Thermo Fisher Scientific had revenue of $10.36B USD in the quarter ending March 29, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to $42.90B, up 0.96% year-over-year. In the year 2024, Thermo Fisher Scientific had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$42.90B
Revenue Growth
+0.96%
P/S Ratio
3.51
Revenue / Employee
$343.18K
Employees
125,000
Market Cap
116.45B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Thermo Fisher Scientific News
- 3 days ago - Thermo Fisher Scientific's Options: A Look at What the Big Money is Thinking - Benzinga
- 5 days ago - Rep. Rick Allen Has Bought Up to $15K Worth Of Intuit Stock: Here's What You Should Know - Benzinga
- 5 days ago - Thermo Fisher acquires Sanofi's New Jersey manufacturing site - Reuters
- 5 days ago - Thermo Fisher Scientific to buy Sanofi production site in New Jersey - Seeking Alpha
- 5 days ago - Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing - Business Wire
- 6 days ago - Peering Into Thermo Fisher Scientific's Recent Short Interest - Benzinga
- 7 days ago - Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine - Business Wire
- 10 days ago - This Thermo Fisher Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga